Ciprofloxacin Treatment in Juvenile Mice Involves Neuronal Activation and Mimics Physical Features of Human Disease
Journal of Orthopaedic Research · 2026
DOI: 10.1002/jor.70095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2026. Verfasst von Nicole A Chittim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Balgrist University Hospital Zurich, University of Zurich, Switzerland. Hauptthemen laut MEDLINE: Ciprofloxacin, Anti-Bacterial Agents, Tendinopathy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by the Swiss Foundation for People with Rare Diseases and internally by the University Hospital Balgrist and University of Zurich..
Abstract (Originalsprache)
Tendinopathy is a complex, painful condition that affects up to 5% of the general population in their lifetime. Antibiotic treatment with fluoroquinolones has been associated with the onset of tendinopathy and tendon rupture. The mechanisms behind fluoroquinolone induced tendinopathy remain unclear. To probe activation of potentially causative pathways, we treated juvenile mice with ciprofloxacin in drinking water for 4 weeks and performed RNA sequencing on tail tendons. We discovered that ciprofloxacin‐treated mice had upregulated genes relating to nerve development. Additionally, treated mice showed downregulation of genes associated with extracellular matrix (ECM) processes. We further explored ECM changes using histological and mechanical testing methods on patellar tendons. We found that ciprofloxacin treatment led to altered cell morphology and proteoglycan density. These changes translated to a decrease in mechanical properties of the patellar tendons. Furthermore, ciprofloxacin‐treated mice had a higher percentage of apoptotic cells, and we confirmed increased presence of nerve cells (Plexin B1 + ) in the patellar tendons compared to controls. Taken together, we showed that ciprofloxacin treatment in juvenile mice induces structural and biological phenotypes commonly associated with fluoroquinolone‐induced tendinopathy and identify the axis of pathological neural activation as a promising area for further exploration. Clinical significance: Oral administration of ciprofloxacin in mice presents a clinically relevant model for studying mechanisms of tendinopathy in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Balgrist University Hospital Zurich, University of Zurich, Switzerland.
- Institute for Biomechanics, ETH Zurich, Zurich, Switzerland.
- Department of Cell and Tissue Dynamics, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
- Center for Cardiovascular Genetics and Gene Diagnostics, Foundation for People with Rare Diseases, Schlieren, Switzerland.
- Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Nicole A Chittim, Amro A Hussien
Förderung
- This study was funded by the Swiss Foundation for People with Rare Diseases and internally by the University Hospital Balgrist and University of Zurich.
Zitieren
APA
Chittim, N. A., Hussien, A. A., Dubacher, N., Matyas, G., & Snedeker, J. G. (2026). Ciprofloxacin Treatment in Juvenile Mice Involves Neuronal Activation and Mimics Physical Features of Human Disease. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.70095
Vancouver
Chittim NA, Hussien AA, Dubacher N, Matyas G, Snedeker JG. Ciprofloxacin Treatment in Juvenile Mice Involves Neuronal Activation and Mimics Physical Features of Human Disease. Journal of Orthopaedic Research. 2026. doi:10.1002/jor.70095
BibTeX
@article{Chittim2026,
author = {Chittim, Nicole A and Hussien, Amro A and Dubacher, Nicolo and Matyas, Gabor and Snedeker, Jess G},
title = {Ciprofloxacin Treatment in Juvenile Mice Involves Neuronal Activation and Mimics Physical Features of Human Disease},
journal = {Journal of Orthopaedic Research},
year = {2026},
doi = {10.1002/jor.70095}
}
EUVIMED